Myriad Genetics Inc (NASDAQ: MYGN) has reported E.P.S. of $-0.36 for its fourth fiscal quarter (ending December 31) versus $-0.52 for the same period a year ago. Relative to the consensus estimate of $0.01, this […]
For its fourth fiscal quarter (ending December 31), Ligand Pharmaceuticals Inc (NASDAQ: LGND) has reported E.P.S. of $1.04 compared to $-0.86 a year ago. This performance was $0.38 better than the consensus estimate of $0.66. […]
ICF International Inc (NASDAQ: ICFI) has reported earnings for its fourth fiscal quarter (ending December 31) of $1.18 versus $0.47 for the same period a year ago — an increase of 151%. However, this result […]
HENRY SCHEIN INC (NASDAQ: HSIC) has reported earnings for its fourth fiscal quarter (ending December 31) of $0.13 versus $0.35 for the same period a year ago — a decline of -63%. Relative to the […]
Extremely important negative changes in investment behavior have recently occurred for Finward Bancorp (NASDAQ: FNWD): negative upside/downside volume developed, and its shorter term price trend turned down. Finward Bancorp (NASDAQ: FNWD). Important negative changes in […]
Dorman Products Inc (NASDAQ: DORM) stock closed at $96.26 on 2/27/24 after a major increase of 15.9%. Moreover, trading volume in this advance was exceptionally high at 273% of normal. The stock has risen 17.1% […]
For its fourth fiscal quarter (ending January 31), Urban Outfitters Inc (NASDAQ: URBN) has reported a 50% increase in E.P.S. from $0.34 a year ago to $0.51 in the current quarter. However, this result fell […]
Trupanion Inc (NASDAQ: TRUP) stock enjoyed a major increase of 13.0% on 2/27/24. The shares closed at $27.27. This advance was accompanied by normal trading volume. The stock has been strong relative to the market […]
The First of Long Island Corp (NASDAQ: FLIC) has recently experienced meaningful negative changes in fundamentals: the stock’s power rating fell below 50, the consensus estimate for December, 2024 decreased significantly, and the consensus estimate […]
R1 RCM INC (NASDAQ: RCM) has reported E.P.S. of $0.00 for its fourth fiscal quarter (ending December 31) versus $-0.10 for the same period a year ago. Relative to the consensus estimate of $0.04, this […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research